"It is scary how many similarities there are between this industry and the mob. The mob makes obscene amounts of money, as does this industry. The side effects of organized crime are killings and deaths, and the side effects are the same in this industry. The mob bribes politicians and others, and so does the drug industry." -- Peter Rost, former Pfizer Vice President of Marketing (source)
CEO OF CRIMINAL FIRM PFIZER REVEALS HIS SENSE OF HUMOUR | Gemma O Doherty
Overcoming the belief that the healthcare industry is largely free of corruption and criminality can be a formidable hurdle for anyone to navigate. Even if one accepts the overwhelming evidence, it is yet another leap to actually factor-in this knowledge when considering information provided by healthcare professionals and pharmaceutical companies. Many people simply will not question the information and advice provided by their doctor, especially when it is a desperate patient facing a life threatening problem. To be sure, front-line healthcare professionals are not always wrong, nor are they always to blame for disseminating inaccurate information; rather it is the healthcare complex as a whole in which the fault lies. I use the term 'healthcare' because it's recognizable, but the more accurate term is 'disease management' because the truth is, the healthcare industry isn't interested in curing disease for the obvious reason that it is immensely more profitable to treat disease indefinitely.
There is more to it than simple greed however; there is also the public mindset that the available science, which is often biased by the same for-profit corporations, is unbiased, well tested and well established. There is also the mindset of the healthcare professional who has paid an enormous amount of money for their education and who thusly seems largely incapable of considering any information from non-mainstream sources which challenge that which they have been taught, regardless of the validity of the conflicting information.
Here we shall primarily concern ourselves with blatant criminality beyond the level of caregiver, focusing instead upon the corporations and institutions that dictate policy, procedure, and manufacture drugs. Following are just a few examples of that criminality. It should be noted that the billions of dollars paid in settlements and fines by pharmaceutical companies seem to be viewed as simply the cost of doing business and rarely are the responsible individuals rooted out and held accountable for their actions.
High Times At The CDC - Sex, Lies And Audiotape | Dr. Brian Hooker
Truth in Media (Big Pharma 4/4): How Big Pharma Rakes In Profits From Deadly Drugs | Ben Swann
Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote | Department of Justice, 2012
In an agreed statement of facts filed in the criminal action, Abbott admits that from 1998 through 2006, the company maintained a specialized sales force trained to market Depakote in nursing homes for the control of agitation and aggression in elderly dementia patients, despite the absence of credible scientific evidence that Depakote was safe and effective for that use. In addition, from 2001 through 2006, the company marketed Depakote in combination with atypical antipsychotic drugs to treat schizophrenia, even after its clinical trials failed to demonstrate that adding Depakote was any more effective than an atypical antipsychotic alone for that use.
CDC Caught Hiding Data Showing Mercury in Vaccines Linked to Autism | Brian Shilhavy, Health Impact News 2019
In a press release issued last year, one that almost no mainstream media sources have bothered to report, it was announced that Dr. Brian Hooker had finally received documents from the CDC through a Freedom of Information Act that revealed the CDC had access to data linking Thimerosal in vaccines to autism, non-organic sleep disorders, and speech disorders.
Two members of Congress helped Dr. Hooker draft his letter to the CDC, after having spent nearly 10 years submitting over 100 Freedom of Information Acts to no avail.
This information was completely blacked out of the mainstream media. This information is very damaging to the CDC, which has stated for years that there are no studies linking the mercury of Thimerosal in vaccines to autism. [...] Thimerosal is still used today in the flu shot that is administered to pregnant women and infants.
CDC vaccine scientist who downplayed links to autism indicted by DOJ in alleged fraud scheme | CDC.news, 2016
CDC researcher Poul Thorsen, who famously headed up the "Denmark Study" that many claim disproved any link between autism and vaccines, has been indicted in Atlanta by a federal grand jury on charges of wire fraud, money laundering and defrauding research institutions of grant money.
Drug Maker Aegerion Agrees to Plead Guilty; Will Pay More Than $35 Million to Resolve Criminal Charges and Civil False Claims Allegations | Department of Justice
Aegerion Pharmaceuticals Inc., a Cambridge, Massachusetts-based subsidiary of Novelion Therapeutics Inc., has agreed to plead guilty to charges relating to its prescription drug, Juxtapid, the Justice Department announced today.
As charged in a criminal information filed today, Aegerion introduced Juxtapid into interstate commerce that was misbranded because, among other things, Aegerion failed to comply with a Risk Evaluation and Mitigation Strategy (REMS). The resolution also includes a deferred prosecution agreement relating to criminal liability under the Health Insurance Portability and Accountability Act of 1996 (HIPAA). In addition, Aegerion has agreed to settle allegations that it caused false claims to be submitted to federal health care programs for Juxtapid. Aegerion has agreed to pay more than $35 million to resolve criminal and civil liability arising from these matters.
Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa | Department of Justice, 2009
Assistant Attorney General for the Civil Division Gregory G. Katsas and acting U.S. Attorney for the Eastern District of Pennsylvania Laurie Magid today announced the filing of a criminal information against Eli Lilly for promoting Zyprexa for uses not approved by the FDA. Eli Lilly, headquartered in Indianapolis, is charged in the information with promoting Zyprexa for such off-label or unapproved uses as treatment for dementia, including Alzheimer's dementia, in elderly people.
Robert F. Kennedy Jr., Chairman of Children’s Health Defense (CHD) and Rolf Hazlehurst, the father of a vaccine-injured child have petitioned Michael Horowitz, the Inspector General of the Department of Justice (DOJ) to investigate the conduct of two DOJ attorneys, Vincent Matanoski and Lynn Ricciardella.
The two attorneys represented the Secretary of Health and Human Services in the National Vaccine Injury Compensation Program (NVICP), otherwise known as the “Vaccine Court,” in the Omnibus Autism Proceedings (OAP). The alleged actions of the two attorneys in the OAP were fraudulent and obstructed justice.
[...]
Kennedy and Hazlehurst allege that Matanoski and Ricciardella acted together to intentionally misrepresent the opinion of one of their own witnesses, Dr. Andrew Zimmerman, to conceal evidence of his true opinion from the Special Masters who presided in the “Vaccine Court” and the petitioners who were seeking justice and compensation.
The evidence that Matanoski and Ricciardella concealed was a report authored by Dr. Zimmerman showing how vaccines may cause autism in a subset of children with underlying mitochondrial issues.
GlaxoSmithKline settles healthcare fraud case for $3 billion | David Ingram, Reuters, 2012
In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also includes civil penalties for improper marketing of a half-dozen other drugs.
GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant | Department of Justice, 2010
The criminal information filed today alleges that SB Pharmco's manufacturing operations failed to ensure that Kytril and Bactroban finished products were free of contamination from microorganisms. The criminal information further alleges that SB Pharmco's manufacturing process caused Paxil CR two-layer tablets to split. The splitting, which the company itself called a "critical defect," caused the potential distribution of tablets that did not have any therapeutic effect and tablets that did not contain any controlled release mechanism.
The criminal information also alleges that Avandamet tablets manufactured by SB Pharmco did not always have the Food and Drug Administration (FDA)-approved mix of active ingredients, and, as a result, potentially contained too much or too little of the ingredient with the therapeutic effect. Finally, the criminal information alleges that SB Pharmco's Cidra facility suffered from longstanding problems of product mix-ups, which caused tablets of one drug type and strength to be commingled with tablets of another drug type and/or strength in the same bottle.
GlaxoSmithKline fined $490m by China for bribery | BBC News, 2014
The record penalty follows allegations the drug giant paid out bribes to doctors and hospitals in order to have their products promoted.
The court gave GSK's former head of Chinese operations, Mark Reilly, a suspended three-year prison sentence and he is set to be deported.
Other GSK executives have also been given suspended jail sentences.
GlaxoSmithKline Found Guilty Of Bribing Doctors To Over-Prescribe | News Punch, 2015
The company encouraged sales reps in the US to mis-sell three drugs to doctors and lavished hospitality and kickbacks on those who agreed to write extra prescriptions, including trips to resorts in Bermuda, Jamaica and California.
The company admitted corporate misconduct over the antidepressants Paxil and Wellbutrin and asthma drug Advair.
Psychiatrists and their partners were flown to five-star hotels, on all-expenses-paid trips where speakers, paid up to $2,500 to attend, gave presentations on the drugs. They could enjoy diving, golf, fishing and other extra activities arranged by the company.
GSK also paid for articles on its drugs to appear in medical journals and "independent" doctors were hired by the company to promote the treatments, according to court documents.
Trump names former GSK executive as head of "Operation Warp Speed" | Big Pharma News, 2020
Even though GSK has been found guilty of committing heinous crimes against humanity in exchange for massive profits, Trump apparently does not mind at all and thinks that one of the company's top dogs is the perfect choice for getting a Wuhan coronavirus (COVID-19) vaccine produced as quickly as possible.
J&J Loses Again, Pays $8B Over Antipsychotic Drug Harm | The Highwire, 2019
Breaking news out of Philadelphia as Reuters is reporting that Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts. The case is one of thousands in Philadelphia alone with more than 13,000 across the country making the drug yet another product Johnson & Johnson must defend against legal challenges in courts across America.
Johnson & Johnson’s public relations department was already in shambles from its legal loss in Oklahoma in which it was ordered to pay $572M in the landmark legal case for causing the opioid crisis in that state.
Johnson & Johnson Coughs Up $2.2 Billion in Drug-Marketing Settlement | Kyle Stock, Bloomberg, 2013
The deal represents the government's third-largest settlement with a pharmaceutical company, yet the deception may still have been worth it for J&J: It sold $24.2 billion of Risperdal from 2003 to 2010.
Johnson & Johnson settles with Ohio counties for $20 million prior to opioid trial | Doha Madani, NBC News, 2019
Johnson & Johnson and its pharmaceutical subsidiary, Janssen, agreed to a $20.4 million settlement with two Ohio counties Tuesday in an effort to avoid a lengthy and costly federal trial about the opioid addiction epidemic.
The opioid manufacturer company said the settlements with Cuyahoga and Summit counties include no admission of liability and removes the Johnson & Johnson from the federal trial scheduled to begin this month in the Northern District of Ohio, according to a news release.
Johnson & Johnson agrees to pay $263 million in New York opioid settlement
New York Attorney General Letitia James said in a statement that “the opioid epidemic has wreaked havoc” across the nation and that “Johnson & Johnson helped fuel this fire.” James said her focus remains “getting funds into communities devastated by opioids as quickly as possible.”
Johnson & Johnson said the settlements were consistent with its prior agreement to pay $5 billion to settle opioid claims by states, cities, counties and tribal governments nationwide. The company and the largest U.S. drug distributors – AmerisourceBergen Corp., Cardinal Health Inc. and McKesson Corp. – have proposed paying a combined $26 billion to end thousands of opioid lawsuits.
Tuesday’s opioids trial was one of several scheduled for this year, with others underway in California and West Virginia. Drugmakers AbbVie Inc. and Teva Pharmaceutical Industries Ltd. and several distributors are among the defendants. Pharmacy chain Walgreens Boots Alliance Inc. is also a defendant, though it was sued only by the counties. (Related: Kentucky sues WALGREENS for promoting opioid epidemic.)
Walmart Inc., Rite Aid Corp. and CVS Health Corp. were detached from the trial during jury selection. CVS reportedly settled with Nassau and Suffolk counties although terms of the settlement have not been disclosed.
Johnson & Johnson has also been appealing an Oklahoma judge’s 2019 ruling that the New Jersey-based company pay that state $465 million for its deceptive marketing of opioids. The Centers for Disease Control and Prevention has said nearly 500,000 people died from opioid overdoses from 1999 to 2019.
Merck Accused of Fraud, Deceit and Negligence in US Gardasil Case | Christina England, BA Hons, GreenMedInfo, 2018
There has been documented evidence that the HPV vaccine has caused more injuries than any other vaccination in history. Despite this evidence however, the HPV vaccination has continued to be hailed a success by the pharmaceutical industry and governments alike.
According to the World Health Organisation’s (WHO) VigiAccess database, as of April 09, 2018, a total of 85,329 reports of adverse reactions have been filed regarding the HPV vaccination. These reports include 37,699 reports of nervous system disorders; 2450 cardiac disorders, (including 38 cardiac arrests) 533 reports of Postural orthostatic tachycardia syndrome (POTS); over 3200 reports of seizures or epilepsy, 8453 syncope and 389 deaths.
Merck Fighting Fraud Lawsuits in U.S. Courts on MMR and Gardasil Vaccines | Brian Shilhavy, Health Impact News, 2019
There are currently two major federal lawsuits against Merck that are being litigated in U.S. courts: a whistleblower lawsuit from former Merck scientists claiming fraud regarding the MMR vaccine, and a lawsuit against the Gardasil vaccine claiming fraud from a 16-year-old girl who allegedly suffered Postural Orthostatic Tachycardia Syndrome (POTS) after receiving the Gardasil vaccine.
In a lawsuit against Merck that was originally filed in 2010, and continues to this day, Stephen Krahling and Joan Wlochowski, former Merck virologists, claim that they “witnessed firsthand the improper testing and data falsification in which Merck engaged to artificially inflate the (MMR) vaccine’s efficacy findings.”
The former Merck scientists claim that Merck’s faulty MMR vaccine has caused the United States to pay “hundreds of millions of dollars for a vaccine that does not provide adequate immunization.”
“As the largest single purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchases), the United States is by far the largest financial victim of Merck’s fraud,” according to the 2010 False Claims Act complaint.
“But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection.
And while this is a disease that, according to the Centers for Disease Control (‘CDC’), was supposed to be eradicated by now, the failure in Merck’s vaccine has allowed this disease to linger, with significant outbreaks continuing to occur.”
Merck has tried, unsuccessfully, to end this case for almost eight years now, in an attempt to hide it from the American public.
Merck to Pay More than $650 Million to Resolve Claims of Fraudulent Price Reporting and Kickbacks | Department of Justice, 2008
WASHINGTON -- Merck & Company has agreed to pay more than $650 million to resolve allegations that the pharmaceutical manufacturer failed to pay proper rebates to Medicaid and other government health care programs and paid illegal remuneration to health care providers to induce them to prescribe the company's products, the Justice Department announced today. The allegations were brought in two separate lawsuits filed by whistleblowers under the qui tam, or whistleblower, provisions of the False Claims Act.
New Evidence of Ongoing Corruption and Scientific Misconduct at CDC | eClinik, 2017
Poul Thorsen is a key figure in the shaky research that denied justice to thousands of families whose children suffered a vaccine related neurological injury (brain and nervous system) that developed into autism spectrum disorder (ASD or autism). Thorsen's influence on US vaccine projects and policies is extensive.
The studies he led had strong influence on the review and outcomes of the Institute of Medicine (now known as the National Academy of Medicine) of the National Academy of Sciences when looking at thimerosal in vaccines. Today, Thorsen is a fugitive from justice since a warrant for his arrest was issued in April 2001. Thorsen was added to the HHS Office of Inspector General's 'Most Wanted' list in April 2012.
Pediatric Doctor Pleads Guilty to Illegally Targeting Teens for Cholesterol Drug Trials | Brian Shilhavy, Health Impact News, 2019
According to court documents, Dr. Eduardo Montaña colluded with pharmaceutical company Aegerion to sell their drug Juxtapid to teenagers with heart problems, even though the drug was not approved for their conditions.
Dr. Montaña violated HIPAA laws of patient privacy by supplying the pharmaceutical company private medical records of 280 teenagers without patient knowledge or consent.
Drug company Aegerion was found guilty of criminal wrongdoing in a Massachusetts court, and a sales representative of the company apparently knew that what they were doing was wrong, as the sales rep allegedly wrote in an email:
"By the way, I am sending this to you from my personal email because of the patient info :)"
Tough on Crime? Pfizer and the CIHR | National Center for Biotechnology Information, 2010
The appointment of Dr. Bernard Prigent, vice-president and medical director of Pfizer Canada, to the Governing Council of the Canadian Institutes of Health Research, outraged many Canadian health researchers. Pfizer has been a "habitual offender," persistently engaging in illegal and corrupt marketing practices, bribing physicians and suppressing adverse trial results. Since 2002 the company and its subsidiaries have been assessed $3 billion in criminal convictions, civil penalties and jury awards. The $2.3-billion settlement in September 2009 - a month before Dr. Prigent's appointment - set a new record for both criminal fines and total penalties. A link with Pfizer might well advance the commercialization of Canadian research - unhindered by law or morality.
Pfizer to Pay $2.3 Billion for Fraudulent Marketing | Department of Justice
WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together "Pfizer") have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department announced today.
Pharmacia & Upjohn Company has agreed to plead guilty to a felony violation of the Food, Drug and Cosmetic Act for misbranding Bextra with the intent to defraud or mislead. Bextra is an anti-inflammatory drug that Pfizer pulled from the market in 2005. Under the provisions of the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its new drug application to FDA. Once approved, the drug may not be marketed or promoted for so-called "off-label" uses – i.e., any use not specified in an application and approved by FDA. Pfizer promoted the sale of Bextra for several uses and dosages that the FDA specifically declined to approve due to safety concerns. The company will pay a criminal fine of $1.195 billion, the largest criminal fine ever imposed in the United States for any matter. Pharmacia & Upjohn will also forfeit $105 million, for a total criminal resolution of $1.3 billion.
In addition, Pfizer has agreed to pay $1 billion to resolve allegations under the civil False Claims Act that the company illegally promoted four drugs – Bextra; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug – and caused false claims to be submitted to government health care programs for uses that were not medically accepted indications and therefore not covered by those programs. The civil settlement also resolves allegations that Pfizer paid kickbacks to health care providers to induce them to prescribe these, as well as other, drugs. The federal share of the civil settlement is $668,514,830 and the state Medicaid share of the civil settlement is $331,485,170. This is the largest civil fraud settlement in history against a pharmaceutical company.
Pfizer CEO, who said online "misinformation" is criminal, is found guilty of "misleading" vaccine statements | Reclaim The Net, 2022
Pfizer CEO Albert Bourla, last year at the Atlantic Council, called people who spread COVID-19 vaccine misinformation "criminals," in his calls for censorship of misinformation online.
However, this year, Dr. Bourla is himself found responsible by the UK's pharmaceutical regulator of making "misleading" statements about vaccination of children.
Drug Maker Pfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks | Department of Justice, 2018
Pharmaceutical company Pfizer, Inc. (Pfizer), based in New York, NY, has agreed to pay $23.85 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs, in violation of the False Claims Act, the Justice Department announced today.
Pfizer Faces $21 Billion in Fines for Pharmacia's Crimes; 32 Other Companies on the Hook | CBS News, 2009
A jury verdict in Wisconsin could expose Pfizer to up to $21 billion in fines after the company was found guilty of gaming Medicaid. It will likely prompt a wave of settlements from other drug companies that are on the hook in this raft of cases.
Pfizer Admits Bribery in Eight Countries | corpwatch, 2012
For three years, Pfizer Italy employees provided free cell phones, photocopiers, printers and televisions to doctors, arranged for vacations (such as "weekend in Gallipoli," "weekend with companion" and "weekend in Rome") and even made direct cash payments (under the guise of lecture fees and honoraria) in return for promises by doctors to recommend or prescribe Pfizer's products.
Growing evidence suggests Pfizer committed widespread fraud in its COVID jab trials | LifeSite, 2022
(Mercola) - In November 2021, Brook Jackson, a whistleblower who worked on Pfizer's Phase 3 COVID jab trial in the fall of 2020, warned she'd seen evidence of fraud in the trial.
Data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side effects lagged way behind. The revelation was published in The British Medical Journal.
American Home Products (owned by Pfizer) - Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability Litigation (2002) | Violation Tracker
Violation Description:
In January 2002 American Home Products announced that it had finalized a $3.75 billion settlement of multi-district litigation concerning alleged harms caused by its diet drug combination known as fen-phen: https://archive.today/2022.11.13-193550/https://www.sec.gov/Archives/edgar/data/5187/000000518702000005/ann10k01.txt
The FDA and the Case of Ketek | New England Journal of Medicine, 2007
Three years ago, the Food and Drug Administration (FDA) approved the drug Ketek (telithromycin), lauding it as the first of a new class of antimicrobial agents that circumvent antibiotic resistance. Since then, Ketek has been linked to dozens of cases of severe liver injury, been the subject of a series of increasingly urgent safety warnings, and sparked two Congressional investigations of the FDA's acceptance of fraudulent safety data and inappropriate trial methods when it reviewed the drug for approval.
[...]
A routine FDA inspection of the practices of the physician who enrolled the most patients — more than 400 — uncovered fraud, including complete fabrication of patient enrollment. The inspector notified FDA criminal investigators, and the physician is currently serving a 57-month sentence in federal prison for her actions. Inspections of nine other sites enrolling high numbers of patients revealed serious violations of trial conduct, raising substantial concerns about the overall integrity of the study. In the end, 4 of the 10 inspected sites were referred for criminal investigation.
Despite these discoveries, FDA managers presented study 3014 to the advisory committee in January 2003 without mentioning the issues of data integrity.
Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015 | Sammy Almashat, M.D., M.P.H., Sidney M. Wolfe, M.D., Michael Carome, M.D., 2016
In September 2012, Public Citizen published an updated analysis of all major financial settlements and court judgments1 between pharmaceutical manufacturers and the federal and state governments from 1991 through July 18, 2012. At the time of the report’s publication, over $30 billion had been paid by the pharmaceutical industry to settle allegations of numerous violations, including illegal off-label marketing and the deliberate overcharging of taxpayer-funded health programs, such as Medicare and Medicaid.
Why Are the Same People Who Failed at Science on Agent Orange in Charge of Vaccine Safety and Developmental Disorders at the CDC? | James Lyons-Weiler, Ph.D., 2018
Boyle and Destefano's Role in Agent Orange Pseudoscience
The CDC study (which lists no authors) that was published did not study any specific mechanism by which Agent Orange might have caused health issues in veterans. Instead, it studied dioxin levels in Vietnam veterans compared to non-Vietnam veterans. The 646 Vietnam veterans studied by CDC who all served in units that were most likely exposed, did not have elevated levels of dioxin as compared to non-Vietnam veterans. This retrospective study seeking differences of levels of dioxin nearly two decades after exposure is a type of epidemiologic study with only a long shot of success. The aims of the study were to determine whether military records could be "used to identify US Army Vietnam veterans who were likely to be exposed to the herbicide Agent Orange".
Dioxin is stored in fat. The study measured dioxin levels in serum.
[...]
It is my professional opinion that no, neither of these individuals is sufficiently competent to be involved in vaccine safety science and interpretation of studies.
Further, it is my professional opinion that both are guilty of intentional and scientific fraud, perpetuated repeatedly and consistently, to hide the association between vaccines and neurodevelopmental disorders.
(1) Boyle informed Congress that no studies have been conducted that compares the rates of autism in vaccinated and unvaccinated Americans. Yet the CDC website clearly reads "Vaccines Do Not Cause Autism". How could any competent scientist make such as stunning conclusion when the science required to answer the question has not been conducted?
(2) Destefano removed results showing increased risk of autism from on-time MMR prior to presenting to the Institutes of Medicine, and prior to publishing the fraudulent study known as "Destefano et al., 2004". Two subgroups are missing: African American boys, and isolated autism. The latter group had increased risk, included boys and girls from any race, who had no other conditions other than autism. That means "anyone".
(3) Boyle personally attempted to reconfigure the study design of that same study in an attempt to make the association of on-time MMR and autism go away. The team played with study design after knowing the increased risk of autism had been found, which is not allowed in objective research. They worked very hard to attempt to make the association go away. They play games with birth certificates, and age-group definitions. Nothing worked. So they simply removed the results.